Search Results - "WONG, B. C. Y."
-
1
Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: a 1‐year prospective study
Published in Alimentary Pharmacology and Therapeutics (01-10-2006)“…Summary Background Safety of traditional Chinese medicine in patients with chronic hepatitis B is unknown. Aim To study the clinical outcome of traditional…”
Get full text
Journal Article -
2
Prevalence, clinical spectrum and health care utilization of gastro‐oesophageal reflux disease in a Chinese population: a population‐based study
Published in Alimentary pharmacology & therapeutics (15-09-2003)“…Summary Background : Population‐based data on gastro‐oesophageal reflux disease in Chinese are lacking. The prevalence, clinical spectrum and health…”
Get full text
Journal Article -
3
Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong
Published in Alimentary pharmacology & therapeutics (01-08-2006)“…Summary Background Clinical features of hepatocellular carcinoma patients are changing because of screening. Aim To examine the clinical features of…”
Get full text
Journal Article -
4
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second‐line treatment of resistant Helicobacter pylori infection
Published in Alimentary pharmacology & therapeutics (01-02-2006)“…Summary Aim To test the efficacy of levofloxacin‐based second‐line therapy for resistant Helicobacter pylori infection. Methods One hundred and six patients…”
Get full text
Journal Article -
5
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second‐line treatment for Helicobacter pylori infection
Published in Alimentary pharmacology & therapeutics (01-02-2003)“…Summary Aim : To test the efficacy of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy for the second‐line treatment of…”
Get full text
Journal Article -
6
Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician‐referred uninvestigated dyspeptic patients in Hong Kong
Published in Alimentary pharmacology & therapeutics (01-08-2005)“…Summary Background: Peptic ulcer disease is mainly caused by Helicobacter pylori infection and the use of non‐steroidal anti‐inflammatory drugs. Aim: To…”
Get full text
Journal Article -
7
Silencing of Jagged1 inhibits cell growth and invasion in colorectal cancer
Published in Cell death & disease (10-04-2014)“…Dysregulated Notch signaling has a critical role in the tumorigenesis. Jagged1, a Notch ligand, is overexpressed in various human cancers. Recent studies…”
Get full text
Journal Article -
8
Outcome of emergency ERCP for acute cholangitis in patients 90 years of age and older
Published in Alimentary pharmacology & therapeutics (01-06-2004)“…Summary Background : An increasing proportion of the general population across the Western World now survives to an advanced age. However, there is limited…”
Get full text
Journal Article -
9
Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer
Published in Gut (01-04-2003)“…Background:E-cadherin is an adhesion molecule involved in tumour invasion/metastasis. Silencing of E-cadherin by promoter CpG methylation has been shown in…”
Get full text
Journal Article -
10
Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation
Published in Gut (01-04-2006)“…Background: E-cadherin methylation is important in gastric carcinogenesis. Reversing hypermethylation may halt the carcinogenic process. We have previously…”
Get full text
Journal Article -
11
Stability of E‐cadherin methylation status in gastric mucosa associated with histology changes
Published in Alimentary pharmacology & therapeutics (01-09-2006)“…Summary Background We have previously shown reversal of E‐cadherin methylation in gastric mucosa from patients with dyspepsia at week 6 after Helicobacter…”
Get full text
Journal Article -
12
Anxiety but not depression determines health care‐seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population‐based study
Published in Alimentary pharmacology & therapeutics (01-12-2002)“…Summary Aims : To study the prevalence of dyspepsia and irritable bowel syndrome and the effects of co‐existing anxiety and depression on health care…”
Get full text
Journal Article -
13
Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin‐induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re‐bleeding risk — a single‐blind, randomized controlled study
Published in Alimentary pharmacology & therapeutics (01-02-2004)“…Summary Background : Clopidogrel causes significantly less symptomatic peptic ulcer disease and gastrointestinal bleeding than low‐dose aspirin in average‐risk…”
Get full text
Journal Article -
14
Positive association between gastro‐oesophageal reflux disease and irritable bowel syndrome in a Chinese population
Published in Alimentary pharmacology & therapeutics (01-05-2007)“…Summary Background Gastro‐oesophageal reflux disease and irritable bowel syndrome are common diseases which may be related. Aim To examine the association…”
Get full text
Journal Article -
15
Long‐term prospective follow‐up of endoscopic oesophagitis in southern Chinese — prevalence and spectrum of the disease
Published in Alimentary pharmacology & therapeutics (01-12-2002)“…Summary Aims : To study the prevalence, clinical characteristics and long‐term outcome of oesophagitis in Chinese patients. Methods : Clinical and endoscopic…”
Get full text
Journal Article -
16
A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro‐oesophageal reflux disease in the Chinese population
Published in Alimentary pharmacology & therapeutics (01-06-2003)“…Summary Background and aims: To develop a validated gastro‐oesophageal disease (GERD) symptom questionnaire for the Chinese population. Methods: One hundred…”
Get full text
Journal Article -
17
Review article: current management of metastatic colorectal cancer – the evolving impact of targeted drug therapies
Published in Alimentary pharmacology & therapeutics (01-06-2008)“…Summary Background The field of colorectal cancer chemotherapy has been transformed by the advent of molecule‐specific drugs. Combined use of such drugs…”
Get full text
Journal Article -
18
Clinical trial: levofloxacin‐based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection
Published in Alimentary Pharmacology and Therapeutics (01-10-2007)“…Summary Background The efficacy of levofloxacin‐based quadruple therapy in resistant Helicobacter pylori infection is not known. Aim To test the efficacy of…”
Get full text
Journal Article -
19
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti‐inflammatory drug users – a randomized trial
Published in Alimentary pharmacology & therapeutics (15-10-2003)“…Summary Aim : To study whether prophylaxis with lansoprazole could prevent relapse of ulcers after eradication of Helicobacter pylori in patients with…”
Get full text
Journal Article -
20
A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population
Published in Alimentary pharmacology & therapeutics (01-11-2003)“…Summary Background : Colorectal cancer screening by guaiac faecal occult blood test has been shown to reduce the incidence and mortality of colorectal cancer…”
Get full text
Journal Article